Related Experiment Video
Updated: Jul 27, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Prognostic Value of Different Levels of Uric Acid in Patients with Coronary Chronic Total Occlusion Undergoing
Mohamed Ayoub1, Kambis Mashayekhi2, Michael Behnes3
1Division of Cardiology and Angiology, Heart Center University of Bochum, 32545 Bad Oeynhausen, Germany.
Insights
High uric acid levels predict mortality in patients undergoing percutaneous coronary intervention for chronic total occlusions. Incorporating uric acid into risk assessment may improve outcomes for these patients.
Area of Science:
- Cardiology
- Biomarkers
- Interventional Cardiology
Background:
- Uric acid (UA) is increasingly recognized as a potential predictor of clinical outcomes after percutaneous coronary intervention (PCI).
- The prognostic significance of UA in patients undergoing PCI specifically for chronic total occlusions (CTO) remains underexplored.
Purpose of the Study:
- To investigate the association between pre-procedural uric acid levels and clinical outcomes in patients with CTO undergoing PCI.
- To determine if uric acid is an independent predictor of all-cause mortality in this specific patient population.
Main Methods:
- A retrospective analysis of 1963 patients with CTO who underwent PCI between 2005 and 2012.
- Patients were stratified into three groups based on pre-angiography uric acid tertiles (<5.5 mg/dL, 5.6-6.9 mg/dL, >7.0 mg/dL).
- Outcomes, including all-cause mortality, were compared among the uric acid tertiles with a median follow-up of 3.0 years.
Main Results:
- Patients in the lowest uric acid tertile (<5.5 mg/dL) had significantly lower all-cause mortality compared to the highest tertile (>7.0 mg/dL) (adjusted HR: 0.67; 95% CI: 0.49-0.92; p=0.012).
- No significant difference in all-cause mortality was observed between the first and second uric acid tertiles (adjusted HR: 0.96; 95% CI: 0.71-1.3; p=0.78).
- Elevated uric acid levels were identified as an independent predictor of all-cause mortality in patients with CTO treated with PCI.
Conclusions:
- High serum uric acid levels are associated with increased all-cause mortality in patients with chronic total occlusions undergoing percutaneous coronary intervention.
- Uric acid measurement should be considered as part of the routine risk stratification for patients with CTO undergoing PCI.
Abstract:
Recent data suggest that uric acid (UA) might be an independent predictor of clinical outcomes following percutaneous coronary intervention (PCI). The predictive value of uric acid in patients undergoing PCI for chronic total occlusions (CTO) is unknown. We included patients with CTO who underwent PCI at our center in 2005 and 2012, with available uric acid levels before angiography. Subjects were divided into groups according to uric acid tertiles (<5.5 mg/dL, 5.6-6.9 mg/dL, and >7.0 mg/dL), and outcomes were compared among the groups. Out of the 1963 patients (mean age 65.2 ± 11 years), 34.7% (n = 682) had uric acid concentrations in the first tertile, 34.3% (n = 673) in the second tertile, and 31% (n = 608) in the third tertile. Median follow-up was 3.0 years. Uric acid levels in the first tertile were associated with significantly lower all-cause mortality, as compared to the third tertile, with an adjusted hazard ratio (HR) of 0.67 (95% confidence interval (CI): 0.49 to 0.92; p = 0.012). No significant differences regarding all-cause mortality were found between patients in the first and second tertiles (HR: 0.96 [95% CI: 0.71 to 1.3; p = 0.78]). High levels of uric acid emerged as an independent predictor of all-cause mortality in patients with chronic total occlusion treated with PCI. Hence, uric acid levels should be incorporated into the risk assessment of patients with CTO.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care